Asymptomatic glycemic instability: How to measure it and which clinical applications?;La variabilité glycémique asymptomatique: Comment l'évaluer et quelle est son incidence clinique?

Diabetes and Metabolism

Volumn 29, Issue 2 I, 2003, Pages 179-188

  Guerci, B ^a  

^a Ctr Hospitalier Univ de Nancy   (France)

Author keywords

Blood Glucose Variability; Brittle diabetes; Continuous Glucose Monitoring; Glycemic Instability; Hypoglycemia; Insulin treated Diabetes; LBGI; MAGE; MIME; MODD

Indexed keywords

GLUCOSE; HEMOGLOBIN; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; DIABETES CONTROL; DIABETES MELLITUS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; INJECTION; INSULIN RELEASE; INSULIN TREATMENT; REPRODUCIBILITY;

EID: 0037957285     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(07)70027-7     Document Type: Article

References (32)

1. Service FJ, Nelson RL. Characteristics of glycemic stability. Diabetes Care, 1980, 3, 58-62.
2. Molnar GD, Taylor WF, Ho MM. Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia, 1972, 8, 342-8.
3. Hansen BC, Jen KC, Belbez Pek S, Wolfe RA. Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans. J Clin Endocrinol Metab, 1982, 54, 785-92.
4. Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, Goetz FC. Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med, 1983, 309, 7-12.
5. Service FJ, Hall LD, Westland RE, et al. Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects. Diabetologia, 1983, 25, 316-21.
6. Van Cauter E, Desir D, Decoster C, Fery F, Balasse EO: Nocturnal decrease in glucose tolerance during constant glucose infusion. J Clin Endocrinol Metab, 1989, 69, 604-11.
7. Service FJ, O'Brien PC, Rizza RA: Measurements of glucose control. Diabetes Care, 1987, 10,225-37.
8. 1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes, 1995, 44, 968-83.
9. Ceriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med, 1998, 15, 188-93.
10. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia, 2001, 44, 2107-14.
11. 1c level. Diabetes Care, 2000, 23, 1830-4.
12. Liljenquist JE, Mueller GL, Cherrington AD, et al. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest, 1977, 59, 369-74.
13. Selam JL. How to measure glycemic instability? Diabetes Metab, 2000, 26,148-51.
14. Koivisto VA, Felig P. Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med, 1980, 92, 59-61.
15. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WE Mean amplitude of glycemic excursions, a measure of dia- betic instability. Diabetes, 1970, 19, 644-55.
16. Schlichtkrull J, Munck O, Jersild M. The M-value, an index of bloodsugar control in diabetes. Acta Med Scan, 1965, 177, 95-102.
17. Mirouze J, Satingher A, Sany C, Jaffiol C. Coefficient d'efficacité insulinique: coefficient M de Schlichtkrull corrigé et simplifié par la technique de l'enregistrement glycémique continu. Diabete, 1963, 267-73.
18. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke W. Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care, 1997, 20, 1655-8.
19. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care, 1998, 21, 1870-5.
20. Catargi B, Breilh D, Roger P, Tabarin A. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump. Diabetes Metab, 2000, 26, 210-4.
21. Catargi B, Breilh D, Gin H, et al. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps. Diabetes Metab, 2001, 27, 323-7.
22. Service FJ, O'Brien PC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia, 2001, 44, 1215-20.
23. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. The Kroc Collaborative Study Group. N Engl J Med, 1984, 311,365-72.
24. Arias P, Kerner W, Zier H, Navascues I, Pfeiffer EF. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care, 1985, 8, 134-40.
25. Selam JL, Raccah D, Jeandidier N, Lozano JL, Waxman K, Charles MA. Randomized comparison of metabolic control achieved by intraperitoneal insulin infusion with implantable pumps versus intensive subcutaneous insulin therapy in type I diabetic patients. Diabetes Care, 1992, 15, 53-8.
26. Hanaire-Broutin H, Broussolle C, Jeandidier N, Renard E, Guerci B, Haardt MJ, Lassmann-Vague V. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation clans le Diabete du Traitement par Implants Actifs. Diabetes Care, 1995, 18, 388-92.
27. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII: results of a double-blind crossover study. Diabetes, 1997, 46, 440-3.
28. 1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care, 1998, 21, 977-82.
29. Colombel A, Murat A, Krempf, M, Kuchly-Anton B, Charbonnel B. Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections. Diabet Med, 1999, 16, 319-24.
30. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care, 2000, 23, B21-9.
31. Cox DJ, Kovatchev BP, Julian DM, et al. Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J Clin Endocrinol Metab, 1994, 79, 1659-62.
32. Kovatchev BP, Cox DJ, Farhy LS, Straume M, Gonder-Frederick L, Clarke WL: Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose. J Clin Endocrinol Metab, 2000, 85, 4287-92.